178 related articles for article (PubMed ID: 2079378)
1. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Bauernfeind A; Jungwirth R; Schweighart S; Theopold M
Infection; 1990; 18 Suppl 3():S155-67. PubMed ID: 2079378
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
3. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
[TBL] [Abstract][Full Text] [Related]
4. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
Knothe H; Shah PM; Eckardt O
Infection; 1991; 19(5):370-6. PubMed ID: 1800379
[TBL] [Abstract][Full Text] [Related]
5. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
7. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
Schito GC; Pesce A; Debbia EA
Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime: comparable evaluation with other orally available cephalosporins. With a note on the role of beta-lactamases.
Cullmann W; Dick W
Zentralbl Bakteriol; 1990 Sep; 273(4):501-17. PubMed ID: 2248685
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
13. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
[TBL] [Abstract][Full Text] [Related]
15. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.
Fung-Tomc JC; Huczko E; Stickle T; Minassian B; Kolek B; Denbleyker K; Bonner D; Kessler R
Antimicrob Agents Chemother; 1995 Feb; 39(2):533-8. PubMed ID: 7726528
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cefdinir with beta-lactamases.
Labia R; Morand A
Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
Wise R; Andrews JM; Thornber D
J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
[TBL] [Abstract][Full Text] [Related]
19. [Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Thabaut A; Meyran M
Pathol Biol (Paris); 1990 May; 38(5):347-51. PubMed ID: 2195446
[TBL] [Abstract][Full Text] [Related]
20. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
Bauernfeind A; Jungwirth R; Eberlein E; Klesel N; Adam F; Isert D; Limbert M; Markus A; Schrinner E; Seibert G
J Antibiot (Tokyo); 1992 Apr; 45(4):505-20. PubMed ID: 1592683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]